Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy.
Saved in:
| Title: | Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy. |
|---|---|
| Authors: | Lutz M; Division of Neurology, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA., Levanti M; Division of Neurology, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA., Karns R; Departments of Gastroenterology, Hepatology & Nutrition, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA., Gourdon G; Sorbonne Université, Inserm, institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France., Lindquist D; Imagine Research Center, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45221, USA., Timchenko NA; Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45221, USA.; Department of Surgery, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA., Timchenko L; Division of Neurology, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45221, USA. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2023 Jun 26; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
